Therapeutic discovery tax credit = help for small bio companies

A tax credit created by healthcare reform law to speed new therapies to market could present significant financial opportunities for small biotechnology companies... 

“This is a new credit designed specifically to encourage investment in new therapies relating to diseases,” said Mark Sims, partner at Cincinnati law firm Keating Muething & Klekamp and co-author of a legal alert on the tax credit...